Benevich Eric

Neurocrine Biosciences Inc.

Chief Commercial Officer

Avg. Two Year Performance

No Purchase Track Record

(6%) Avg. Sale Return (3%) Compound

Holdings: 40.78K shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions